by Talking Medicines | May 28, 2021
Customer Engagement remains one of the most prevalent emerging trends. This blog breaks down the different aspects that can be identified throughout the idea of Patient Engagement, from online patient communities to thought leadership in the pharmaceutical industry. ...
by Talking Medicines | May 25, 2021
We continue to contribute toward the scientific validation of analysing social media to listen to the Voice of the Patient. We are advancing knowledge in this field through AI. Read a summary of the publication below put together by Talking Medicines. Background...
by Talking Medicines | May 19, 2021
If 86% of buyers are willing to pay more for a great customer experience, then it is even more important to understand the voice of the customer. Therefore, 44% of corporations now operate voice of the customer programs to driver customer experience and...
by Talking Medicines | Jan 14, 2021
Using existing drugs in different, unintended therapy areas is no new proposition. Exploring other uses of medicines can result in the bypass of significant obstacles that exist in the traditional roadmap of a drug’s development. Reduced research time and lesser...
by Talking Medicines | Oct 30, 2020
A couple of weeks ago our COO, Dr Elizabeth Fairley took part in a panel discussion about the feasibility of MedTech in the developing world and whether it can be a sustainable model.2 We represent a different proposition to the other panellists, their experience is...
by Talking Medicines | Oct 21, 2020
The understanding of mental health has accelerated over the past decade, with the stigma slowly fading away. In the past year alone there has been a substantial shift with the government directly addressing the scale of the issue through making a £5 Million budget...
